期刊文献+

The role of Fusobacteriu mnucleatum in colorectal cancer:from carcinogenesis to clinical management 被引量:6

原文传递
导出
摘要 Colorectal cancer(CRC)is a common malignant tumor that affects people worldwide.Metagenomic analyses have shown an enrichment of Fusobacterium nucleatum(F.nucleatum)in colorectal carcinoma tissue;many studies have indicated that F.nucleatum is closely related to the colorectal carcinogenesis.In this review,we provide the latest information to reveal the related molecular mechanisms.The known virulence factors of F.nucleatum promote adhesion to intestinal epithelial cells via FadA and Fap2.Besides,Fap2 also binds to immune cells causing immunosuppression.Furthermore,F.nucleatum recruits tumor-infiltrating immune cells,thus yielding a pro-inflammatory microenvironment,which promotes colorectal neoplasia progression.F.nucleatum was also found to potentiate CRC development through toll-like receptor 2(TLR2)/toll-like receptor 4(TLR4)signaling and microRNA(miRNA)-21 expression.In addition,F.nucleatum increases CRC recurrence along with chemoresistance by mediating a molecular network of miRNA-18a*,miRNA-4802,and autophagy components.Moreover,viable F.nucleatum was detected in mouse xenografts of human primary colorectal adenocarcinomas through successive passages.These findings indicated that an increased number o f F.nucleatum in the tissues is a biomarker for the diagnosis and prognosis of CRC,and the underlying molecular mechanism can probably provide a potential intervention treatment strategy for patients with F.nucleatum-associaied CRC.
出处 《Chronic Diseases and Translational Medicine》 CSCD 2019年第3期178-187,共10页 慢性疾病与转化医学(英文版)
  • 相关文献

同被引文献16

引证文献6

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部